Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126

Neurobiol Dis. 2000 Aug;7(4):299-309. doi: 10.1006/nbdi.2000.0301.

Abstract

Prion diseases are neurodegenerative pathologies characterized by the accumulation, in the brain, of altered forms of the prion protein (PrP), named PrP(Sc). A synthetic peptide homologous to residues 106-126 of PrP (PrP106-126) was reported to maintain the neurodegenerative characteristics of PrP(Sc). We investigated the intracellular mechanisms involved in PrP106-126-dependent degeneration of primary cultures of cerebellar granule neurons. Prolonged exposure of such neurons to PrP106-126 induced apoptotic cell death. The L-type voltage-sensitive calcium channel blocker nicardipine reproduced this effect, suggesting that blockade of Ca(2+) entry through this class of calcium channels may be responsible for the granule cell degeneration. Microfluorometric analysis showed that PrP106-126 caused a reduction in cytosolic calcium levels, elicited by depolarizing K(+) concentrations in these neurons. Electrophysiological studies demonstrated that PrP106-126 and nicardipine selectively reduce the L-type calcium channel current. These data demonstrate that PrP106-126 alters the activity of L-type voltage-sensitive calcium channels in rat cerebellar granule cells and suggest that this phenomenon is related to the cell death induced by the peptide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / drug effects*
  • Calcium Channels, L-Type / physiology
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cells, Cultured
  • Cerebellum / drug effects*
  • Cerebellum / physiology
  • Neurons / drug effects*
  • Neurons / physiology
  • Nicardipine / pharmacology
  • Peptide Fragments / pharmacology*
  • Prions / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Peptide Fragments
  • Prions
  • prion protein (106-126)
  • Nicardipine

Grants and funding